These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16252907

  • 1. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC.
    J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
    [Abstract] [Full Text] [Related]

  • 2. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK.
    J Med Chem; 1998 May 07; 41(10):1688-95. PubMed ID: 9572894
    [Abstract] [Full Text] [Related]

  • 3. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

  • 4. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
    Pettit GR, Temple C, Narayanan VL, Varma R, Simpson MJ, Boyd MR, Rener GA, Bansal N.
    Anticancer Drug Des; 1995 Jun 16; 10(4):299-309. PubMed ID: 7786396
    [Abstract] [Full Text] [Related]

  • 5. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
    Pettit GR, Rhodes MR, Herald DL, Chaplin DJ, Stratford MR, Hamel E, Pettit RK, Chapuis JC, Oliva D.
    Anticancer Drug Des; 1998 Dec 16; 13(8):981-93. PubMed ID: 10335271
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J, Pontikis R, Florent JC, Monneret C.
    Org Biomol Chem; 2005 Jul 21; 3(14):2657-60. PubMed ID: 15999202
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 8. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR, Lippert JW.
    Anticancer Drug Des; 2000 Jun 15; 15(3):203-16. PubMed ID: 11049088
    [Abstract] [Full Text] [Related]

  • 9. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
    Pettit GR, Lippert JW, Boyd MR, Verdier-Pinard P, Hamel E.
    Anticancer Drug Des; 2000 Oct 15; 15(5):361-71. PubMed ID: 11354312
    [Abstract] [Full Text] [Related]

  • 10. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR, Thornhill A, Melody N, Knight JC.
    J Nat Prod; 2009 Mar 27; 72(3):380-8. PubMed ID: 19228038
    [Abstract] [Full Text] [Related]

  • 11. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
    Pettit GR, Toki BE, Herald DL, Boyd MR, Hamel E, Pettit RK, Chapuis JC.
    J Med Chem; 1999 Apr 22; 42(8):1459-65. PubMed ID: 10212132
    [Abstract] [Full Text] [Related]

  • 12. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K, Hentzen J, dit Chabert JF, Ducki S, Gani OA, Sylte I, Skrede M, Flørenes VA, Hansen TV.
    Bioorg Med Chem; 2008 May 01; 16(9):4829-38. PubMed ID: 18396050
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C, Giraud A, Provot O, Hamze A, Bignon J, Liu JM, Thoret S, Dubois J, Brion JD, Alami M.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3266-71. PubMed ID: 18477509
    [Abstract] [Full Text] [Related]

  • 14. Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.
    Tanpure RP, Strecker TE, Chaplin DJ, Siim BG, Trawick ML, Pinney KG.
    J Nat Prod; 2010 Jun 25; 73(6):1093-101. PubMed ID: 20496923
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
    Pettit GR, Anderson CR, Herald DL, Jung MK, Lee DJ, Hamel E, Pettit RK.
    J Med Chem; 2003 Feb 13; 46(4):525-31. PubMed ID: 12570374
    [Abstract] [Full Text] [Related]

  • 16. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
    Simoni D, Romagnoli R, Baruchello R, Rondanin R, Grisolia G, Eleopra M, Rizzi M, Tolomeo M, Giannini G, Alloatti D, Castorina M, Marcellini M, Pisano C.
    J Med Chem; 2008 Oct 09; 51(19):6211-5. PubMed ID: 18783207
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M, Sun Q, Yang C, Chen D, Ding J, Chen Y, Lin L, Xie Y.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):869-73. PubMed ID: 17174089
    [Abstract] [Full Text] [Related]

  • 18. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I, Carr M, O'Boyle N, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.
    J Enzyme Inhib Med Chem; 2010 Apr 15; 25(2):180-94. PubMed ID: 20222762
    [Abstract] [Full Text] [Related]

  • 19. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
    Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F.
    J Med Chem; 1995 May 12; 38(10):1666-72. PubMed ID: 7752190
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM, Carr M, Greene LM, Bergin O, Nathwani SM, McCabe T, Lloyd DG, Zisterer DM, Meegan MJ.
    J Med Chem; 2010 Dec 23; 53(24):8569-84. PubMed ID: 21080725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.